Maternally Expressed 3 (MEG3) has also been found to be downregulated in NSCLC, while exogenous MEG3 has been shown to significantly inhibit cell proliferation and induce cell apoptosis through the activation of p53 (42). The gene discussed is TP53; the disease is non-small cell lung carcinoma.